StockData
LENZ Therapeutics, Inc. logo

LENZ Therapeutics, Inc. (LENZ) stock

LENZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3055% below fair value
$3.50−0.32 (-8.38%)

Close on Nov 17, 2026Market cap $109.97MP/E –Yield –

LENZ Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

LENZ Therapeutics's market cap was $129.12M on Nov 11, 2026, against $872.51M a year earlier. Over the last 5 years it ranged from $30.18M to $1.33B, with a median of $130.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$129.12M-71.8%
2025Dec 31, 2025$457.41M-42.3%
2024Dec 31, 2024$793.37M+2064.0%
2023Dec 29, 2023$36.66M-21.3%
2022Dec 30, 2022$46.60M-73.3%
2021Dec 31, 2021$174.25M–

More LENZ Therapeutics figures

See a number that looks wrong?